MT-3534
- Generic Name
- MT-3534
Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers
Phase 1
Active, not recruiting
- Conditions
- Healthy Adult Male Volunteers
- Interventions
- Biological: Placebo
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 56
- Registration Number
- NCT06482346
- Locations
- 🇯🇵
Clinical Research Hospital Tokyo, Shinjuku-ku, Tokyo, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath